MENARINI is a fully integrated privately owned pharma company with a long and successful heritage in strategic partnering across the globe. We have a profound know-how stemming from our strong R&D capabilities in key therapeutic areas, coupled with our excellence in commercial execution and our powerful direct presence on a global basis.
Cardiology
Cardiovascular diseases represent the main commitment of Menarini thanks to the company’s experience of more than 30 years in making innovative cardiovascular drugs available for the patients. Menarini is focused on treating the most widespread diseases of the cardiovascular area and on the prevention and reduction of risk factors associated with chronic conditions like hypertension and angina with the commitment to help patients in restoring their quality of life. Basing on the company’s vision, Menarini has focused its energy also on the research to optimise existing therapeutic tools and on creating new, innovative drugs and therapeutic aids.